Gemcitabine
Found 8 free book(s)
Intravesical Administration of Therapeutic Medication for ...
www.suna.orgC. Gemcitabine: 1. Follow institutional policies for preparation of hazardous medications when preparing Gemcitabine. 2. Use Gemcitabine powder for injection 1 g or 2 g vials. 3. Reconstitute Gemcitabine 1000 mg/ 50 mL normal saline or 2000 mg/ 50-100 mL normal saline, or use premixed gemcitabine with closed system administration set.
DRUG NAME Gemcitabine - BC Cancer
www.bccancer.bc.caGemcitabine, a pyrimidine analog, is structurally similar to cytarabine, but has a wider spectrum of antitumour activity due to its different cellular pharmacology and mechanism of action.1 Gemcitabine is metabolized intracellularly to two active metabolites, gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). The cytotoxic
For the Patient Gemcitabine Other names: GEMZAR®
www.bccancer.bc.caGemcitabine For the Patient: Gemcitabine Other names: GEMZAR® • Gemcitabine (jem-SITE-a-been) is a drug that is used to treat some kinds of cancer. It is a clear liquid that is injected into a vein. • A blood test may be taken before each treatment. The dose and timing of your chemotherapy may be changed based on the test results and/or other side effects.
R-GDP: Rituximab, Gemcitabine, Dexamethasone &Cisplatin
nssg.oxford-haematology.org.ukGemcitabine: limited information, consider dose reduction if bilirubin elevated. If bilirubin >27 micromol/L, then initiate treatment at 800 mg/m 2. R educe gemcitabine and cisplatin doses to 75 % and 50% doses for all other grade 3 or 4 non - haematological toxicities respectively.
PATIENT INFORMATION Gemcitabine for Bladder Cancer
www.wsh.nhs.ukGemcitabine for Bladder Cancer This information sheet has been given to you to explain the use of gemcitabine to treat your non-muscle invasive bladder cancer. Sometimes this type of cancer is known as superficial bladder cancer. We are offering you this treatment as the standard treatment is currently unavailable.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eucombination with gemcitabine, 41% were 65 years and older and 10% were 75 years and older. In patients aged 75 years and older who received Abraxane and gemcitabine, there was a higher incidence of serious adverse reactions and adverse reactions that led to treatment discontinuation (see section 4.4). Patients
Extended-infusion piperacillin/tazobactam (Zosyn ...
asp.mednet.ucla.eduGemcitabine Haloperidol Hydroxyzine Idarubicin Mitomycin Mitoxantrone Nalbuphine Prochlorperazine Promethazine Streptozocin Tobramycinb Cisatracuriumc Vancomycind aTable lists known Y-site incompatibilities with pip/tazo, for all other agents, refer to Micromedex for compatibility information
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
pi.lilly.comGEMZAR (gemcitabine)for injection, for intravenous use Initial U.S. Approval: 1996-----RECENT MAJOR CHANGES-----Warnings and Precautions, Hemolytic Uremic Syndrome (5.4) 5/2019-----INDICATIONS AND USAGE----- GEMZAR® is a nucleoside metabolic inhibitor indicated: • incombination with carboplatin, for the treatment of advanced ...